1. Anasti JN. Premature ovarian failure: an update. Fertil Steril 1998; 70: 1–15.
2. Arango NA, Lovell-Badge R, Behringer RR. Targeted mutagenesis of the endogenous mouse Mis gene promoter: in vivo definition of genetic pathways of vertebrate sexual development. Cell 1999; 99: 409–19.
3. Baarends WM, Uilenbroek JT, Kramer P et al. Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology 1995; 136: 4951–62.
4. Behringer RR, Finegold MJ, Cate RL Miillerian-inhibiting substance function during mammalian sexual development. Cell 1995; 79: 415–25.
5. Bukman A, Heineman MJ et al.Ovarian reserve testing and the use of prognostic models in patient with subfertility human Reproduction Update 2001; 7 (6): 581–90.
6. Bulun SE. Clinical review 78: aromatase deficiency in women and men: would you have predicted the phenotypes? J Clin Endocrinol Metab 1996; 81: 867–71.
7. Burger HG, Cahir N, Robertson DM et al. Serum inhibin A and B fall differentially as FSh rise in perimenopausal women. Clin Endocrinol (Oxf) 1998; 48: 809–13.
8. Conway GS, Katlas G, Patel et al. Characterization of idiopathic premature ovarian failure. Fertil Steril 1996; 65: 337–41.
9. Cramer DW. Epidemiologic aspects of early menopause and ovarian cancer. Ann NY Acad Sci 1990; 592: 363–75.
10. De Paolo LV, Ricsak TA, Erickson GF et al. Follistalin and activin: A potential intrinsic regulatory system within diverse tissues. Proc Soc Exp Biol Med 1991; 198: 500–12.
11. Durlinger AL, Gruijters MJ, Kramer P et al. Anti-mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 2001; 142: 4891–9.
12. Durlinger AL, Kramer P, Karels B et al. Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology 1999; 140: 5789–96.
13. Fancin R, Schonauer LM et al. Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than inhibin B, estradiol, FSH and LH on day 3. Hum Reproduct 2003; 18 (2): 323–7.
14. Fraser HM, Tsonis CG. Manipulation of inhibin during the lutheal-follicular phase transition of the primate menstrual cycle fails to affect FSH secretion. J Endocrinol 1994; 142: 181–6.
15. Howel S, Shalet S, Gonadal damage from chemotherapy and radiotherapy. Endocrinol Methab Clin Noth Am 1998; 27: 927–43.
16. Jost A. Recherches sur la differenciation sexuelle de I'embryon de lapin. Arch Anal Microsc Morphol Exp 1947; 36: 271–315.
17. Klein NA, Illingworth PJ, McNeilly AS et al. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrin Metab 1996; 81: 2742–5.
18. Lahlou N, Chabbert-Buffet N, Cristin-Maitre S et al. Main inhibitor of follicle-stimulatin hormone in the lutheal-follicle transition: inhibin A, estradiol, or inhibin B? Hum Reprod 1999; 14: 1190–3.
19. Lamp T, Schultz-Lobmeyr I, Obruca A et al. Premature ovarian failure: etiology and prospects. Gynecol Endocrinol 2000; 14: 292–302.
20. Latronico AC, Anasti J, Atnhold IJP et al. Brief report: teasticular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N Eng J Med 1996; 334: 507–12.
21. Le Nestour E, Marraoui J, Lahlou N et al. Role of estradiol in the rise in the follicle-stimulating hormone levels during the lutheal-follicular transition. J Clin Endocrinol Metab 1993; 77: 439–42.
22. Lee MM, Donahoe PK. Muillerian inhibiting substance: a gonadal hormone with multiple functions. Endocr Rev 1993; 14: 152–64.
23. Licciardi FL, Liu HC, Rosenwaks Z. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril 1995; 64: 991–4.
24. Ling N,Ying SY, Ueno N et al. Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature 1986; 321: 779–82.
25. Lockwood GM, Ledger WL, Barlow DH. Identification of the source of inhibins at the time of conception provides a diagnostic role for them in very early pregnancy. Am J Reprod Immimol 1998; 40: 303–8.
26. Luborsky JL, Meyer P et al. Premature menopause in a multiethnic population study of the menopause transition. Hum Reprod 2003; 18: 199–206.
27. Magoffin DA, Jakimiuk AJ. Inhibin A, Inhibin B and activin in the follicular fluid of regulatory cycling women. Hum Reprod 1997; 12: 1714–9.
28. Meunier H, Rivier C, Evans RM, Vale W. Gonadal and extragonadal expression of inhibin alpha, beta A, and beta U subunits in various tissues predicts diverse functions. Proc Ncitl Aciid Sci USA 1988; 85: 247–51.
29. Moraes Ruhsen, M and Jones, G.S Premature ovarian failure Fertil Steril 1967; 18: 440–61.
30. Muntz W, Mohamed EH, Seufert R et al. Serum inhibin A, inhibin B, pro-a C and activin A levels in women with idiopathic premature ovarian failure. Fertil Steril 2004 Sep; 82 (3): 760–2.
31. Nelson LM, Anasti JN, Kimzey LM et al. Development of luteinized graaf follicles in patients with karyotipically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab 1994; 79: 1470–5.
32. Pangas SA, Woodruff TK. Activin signal transduction pathways. Trends Endocrinol Methab 2000; 11: 309–14.
33. Petraglia F, Hartmann B, Luisi S. Loe levels of serum inhibin A and inhibin B in women with hypergonadotropic amenorrhea and evidence of high levels of activin A in women with hypothalamic amenorrhea. Fertil Steril 70 (5): 907–12.
34. Piek E, Heldin CH, Ten Dijke P.. Specificity diversity, and regulation in TGF-beta superfamily signaling. FASEB J 1999; 13: 2105–24.
35. Reame NE, Wyman TL, Phillips DJ et al. Net increase in stimulatory tone resulting from a decrease in inhibin-B and an increase in activin A may contribute, in part, to the rise in follicular fase FSH of aging in cycling women. J Clin Endocrinol Metab 1998; 83: 3302–7.
36. Rebar RW. Hypergonadotropic amenorrhea and premature ovarian failure: a review. J Reprod Med 1982; 4: 179–86.
37. Richardson SJ, Senikas V, Nelson JF. Follicular depletion during the menopausal transition: Evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 1987; 65: 1231–7.
38. Roberts VJ, Barth S, EI-Roeiy A, Yen SSC. Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. J Clin Endocrinol Metab 1993; 77: 1402–10.
39. Hofman S, GE, Oehninger S et al. Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in vitro fertilization. Fertil Steril 1990; 54: 297–302.
40. Seifer DB, Lambert-Messerlian G, Hogan JW et al. Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertil Steril 1997; 67: 110–4.
41. Seifer DB, Scott RT, Bergh PA et al. Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in follicle-stimulating hormone. Fertile Steril 1999; 72: 63–5.
42. te Velde ER, Pearson PL. The variability of female reproductive aging. Hum Reprod Update 2002; 8: 141–54.
43. te Vigier B, Picard JY, Tran D et al. Production of anti-Muillerian hormone: another homology between Sertoli and granulosa cells. Endocrinology 1984; 114: 1315–20.
44. Vale W, Rivier J, Vaughan J et al. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 1986; 321: 776–9.
45. van Rooij AJ, Broekmans JM, Sheffer GJ. Serum antimulerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study Fert Steril 2005; 8: 979–87.
46. van Rooij IA, Broekmans FJ, te Velde ER et al. Serum antimullarian hormone levels: a novel measure of ovarian reserve. Hum Reprod 2002; 17: 3065–71.
47. Welt CK, McNicholl D, Taylor AE, Hall JE. Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab 1999; 84: 105–11.
48. Welt CK, Pagan YL, Smith PC et al. Control of follicle-stimulation hormone by estradiol and the inhibins: critical role of estradiol at the hypothalamus during the lutheal-follicular transition. J Clin Endocrinol Metab 2003; 88: 1766–71.
49. Woodruff TK, Mather JP. Inhibin, activin and the female reproductive axis. Annu Rev Physiol 1995; 57: 219–44.

Л.А.Марченко, Н.В.Александрова

ГУ НЦАГиП РАМН (ГУ Научный центр акушерства, гинекологии и перинатологии (дир. – акад. РАМН В.И. Кулаков)) 
РАМН, Москва